Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Laura Orsolini, Stefania Chiappini, John M. Corkery, Amira Guirguis, Duccio Papanti & Fabrizio Schifano. (2019) The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Review of Neurotherapeutics 19:12, pages 1253-1264.
Read now
Read now
Kirsten Elin Smith & Michele Staton. (2019) Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?. Substance Abuse 40:2, pages 160-169.
Read now
Read now
Laura E. Kunst & Winifred A. Gebhardt. (2018) Prevalence and Psychosocial Correlates of Party-Drug Use and Associated Problems among University Students in the Netherlands. Substance Use & Misuse 53:12, pages 2077-2088.
Read now
Read now
Matej Sande, Mina Paš, Klara Nahtigal & Simona Šabić. (2018) Patterns of NPS Use and Risk Reduction in Slovenia. Substance Use & Misuse 53:9, pages 1424-1432.
Read now
Read now
Attila Szabo, Lilla Jobbágy & Ferenc Köteles. (2018) Super Pill is Less Effective than an Ordinary Mint in Altering Subjective Psychological Feeling States within a Few Minutes. The Journal of General Psychology 145:2, pages 208-222.
Read now
Read now
Marina Barnard, Christopher Russell, Neil McKeganey & Tiffany Hamilton-Barclay. (2017) The highs and lows of NPS/“Legal High” use: Qualitative views from a UK online survey. Drugs: Education, Prevention and Policy 24:1, pages 96-102.
Read now
Read now
Diana S. Dolliver & Joseph B. Kuhns. (2016) The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment. Journal of Psychoactive Drugs 48:5, pages 321-329.
Read now
Read now
Articles from other publishers (22)
Jan van Amsterdam, Nicholas Burgess & Wim van den Brink. (2023) Legal Approaches to New Psychoactive Substances: First Empirical Findings. European Addiction Research, pages 1-10.
Crossref
Crossref
Marion Istvan, Vincent Bresdin, Marie Mainguy, Pauline Laigo, Marie Grall-Bronnec, Vincent Eudeline, Jean-Emmanuel Guillet, Manon Guillo, Laurent Babonnaud, Pascale Jolliet, Benoit Schreck & Caroline Victorri-Vigneau. (2023) First results of the French OCTOPUS survey among festival attendees: a latent class analysis. Harm Reduction Journal 20:1.
Crossref
Crossref
Rosalind Gittins, Roya Vaziri & Ian Maidment. (2023)
‘
It's a horrible situation for everyone
’: The impact of over the counter and prescription medication misuse on friends and family
. Drug Science, Policy and Law 9.
Crossref
Crossref
Aysel Sultan. (2021) ‘What’s the Problem Represented to Be?’ The Place and Wellbeing of Young People in Azerbaijan’s Drug Policy. Child Indicators Research 15:4, pages 1163-1178.
Crossref
Crossref
Minqi Zhao. (2019) The Illicit Supply of New Psychoactive Substances Within and From China: A Descriptive Analysis. International Journal of Offender Therapy and Comparative Criminology 66:5, pages 495-516.
Crossref
Crossref
Frana-Katica Batistic, Damien Rhumorbarbe, Elodie Lefrancois, Justice Tettey, Martin Raithelhuber, Quentin Rossy & Marie Morelato. (2021) Analysis of Google Trends to monitor new psychoactive substance. Is there an added value?. Forensic Science International 326, pages 110918.
Crossref
Crossref
Dirk Korf, Annemieke Benschop, Bernd Werse, Gerrit Kamphausen, Katalin Felvinczi, Katarzyna Dąbrowska, Susana Hernriques, Ton Nabben, Łukasz Wieczorek, Michał Bujalski, Zsusza Kalo, Evelyn Hearne & Marie Claire Van Hout. (2019) How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe. International Journal of Mental Health and Addiction 19:4, pages 873-890.
Crossref
Crossref
Minqi Zhao. (2020) New Psychoactive Substances and Law Enforcement Responses in a Local Context in China—a Case Study of Methcathinone. Asian Journal of Criminology 15:4, pages 267-284.
Crossref
Crossref
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Crossref
Annemieke Benschop, Róbert Urbán, Máté Kapitány-Fövény, Marie Claire Van Hout, Katarzyna Dąbrowska, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Joana Paula Silva, Łukasz Wieczorek, Bernd Werse, Michal Bujalski, Dirk Korf & Zsolt Demetrovics. (2020) Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology 34:6, pages 600-611.
Crossref
Crossref
Luca Zamengo, Giampietro Frison & Guus Zwitser. (2018) Understanding and managing the new psychoactive substances phenomenon: a holistic approach. Journal of Public Health Policy 40:2, pages 217-235.
Crossref
Crossref
Matteo Caloro, Giuseppa Calabrò, Eleonora de Pisa, Enrico Rosini, Georgios D. Kotzalidis, Davide Lonati, Carlo Alessandro Locatelli, Pietro Papa, Fabrizio Schifano & Paolo Girardi. (2018) Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder. Journal of Addiction Medicine 12:3, pages 247-251.
Crossref
Crossref
Marie Claire Van Hout, Annemieke Benschop, Michal Bujalski, Katarzyna Dąbrowska, Zsolt Demetrovics, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Dirk Korf, Joana Paula Silva, Łukasz Wieczorek & Bernd Werse. (2017) Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries. International Journal of Mental Health and Addiction 16:2, pages 480-495.
Crossref
Crossref
Rosalind Gittins, Amira Guirguis, Fabrizio Schifano & Ian Maidment. (2018) Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK. Brain Sciences 8:4, pages 58.
Crossref
Crossref
Bernd Werse & Dirk Egger. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
217
228
.
Marie Claire Van Hout. (2016) The Dynamic Landscape of Novel Psychoactive Substance (NPS) Use in Ireland: Results from an Expert Consultation. International Journal of Mental Health and Addiction 15:5, pages 985-992.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Rachel Sutherland, Raimondo Bruno, Amy Peacock, Simon Lenton, Allison Matthews, Caroline Salom, Paul Dietze, Kerryn Butler, Lucinda Burns & Monica J. Barratt. (2017) Motivations for new psychoactive substance use among regular psychostimulant users in Australia. International Journal of Drug Policy 43, pages 23-32.
Crossref
Crossref
Marie Claire Van Hout & Evelyn Hearne. (2017) New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. International Journal of Drug Policy 40, pages 102-110.
Crossref
Crossref
Allison Matthews, Rachel Sutherland, Amy Peacock, Joe Van Buskirk, Elizabeth Whittaker, Lucinda Burns & Raimondo Bruno. (2017) I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances. International Journal of Drug Policy 40, pages 44-49.
Crossref
Crossref
Moritz Berning & Anita Hardon. (2016) Educated Guesses and Other Ways to Address the Pharmacological Uncertainty of Designer Drugs. Contemporary Drug Problems 43:3, pages 277-292.
Crossref
Crossref
Bernd Werse & Dirk Egger. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
16
.